Category: Federal Forum Posters
Purpose: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death world-wide and affects over 11 million Americans. There is a three-fold higher COPD prevalence in the veteran population. There is a high economic impact associated with COPD, with direct costs of $29.5 billion and indirect costs of $20.4 billion. Within five years of hospital discharge for a COPD exacerbation, there was a 44% risk for re-hospitalization and a 55% mortality rate. The objective of this study is to evaluate the impact of the implementation of an outpatient, clinical pharmacist-driven transitions of care program for COPD.
Methods: This is a retrospective study where patient charts will be reviewed from January to March 2018. Veteran patients at the Phoenix VA Health Care System with a diagnosis of COPD who require a COPD-related emergency room visit or hospital admission will be identified either by population health management tool or other defined processes. Upon forty-eight hours post-discharge, the patient will have contact with a registered nurse. Within seven to fourteen days post-discharge, the patient will be seen by a Clinical Pharmacist Specialist (CPS). During this initial face-to face visit, the CPS will assess the patient’s COPD status, optimize therapy, ensure immunizations are up-to-date, and refer to specialty care when appropriate. At thirty days post-discharge, the patient will be seen by their primary care provider. At sixty days post-discharge, the patient will be contacted by the CPS for follow-up to assess for symptom improvement or changes, reinforce medication adherence, follow-up on referrals as necessary, and assess use of a COPD action plan.
Results: Not applicable
Conclusion: Not applicable
Emily Choe– PGY1 Ambulatory Care Pharmacy Resident, Phoenix VA Health Care System, Phoenix, AZ